{"transactions":[{"id":1578035,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-03-13T22:44:49.000Z","date":"2024-03-11","kind":"exercise","planned":false,"acquired":false,"shares":4908,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2024 and each March 10 thereafter, until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2024 and each March 10 thereafter, until fully vested."}],"balance_after":44182,"derivative":{"underlying":"Common Stock","underlying_shares":4908},"source":{"system":"sec-edgar","filing":"0001415889-24-007863","document":"form4-03132024_100341.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000141588924007863/form4-03132024_100341.xml","form_type":"4"}},{"id":1578034,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-13T22:44:49.000Z","date":"2024-03-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":1912,"price":7.22,"value":13804.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by and surrendered to the Issuer on March 11, 2024, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award."}],"balance_after":97465,"source":{"system":"sec-edgar","filing":"0001415889-24-007863","document":"form4-03132024_100341.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000141588924007863/form4-03132024_100341.xml","form_type":"4"}},{"id":1578033,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-13T22:44:49.000Z","date":"2024-03-11","kind":"exercise","planned":false,"acquired":true,"shares":4908,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":99377,"source":{"system":"sec-edgar","filing":"0001415889-24-007863","document":"form4-03132024_100341.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000141588924007863/form4-03132024_100341.xml","form_type":"4"}},{"id":1624468,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-02-22T22:34:52.000Z","date":"2024-02-20","kind":"exercise","planned":false,"acquired":false,"shares":1752,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the RSU Award shall vest quarterly over four years, with 4/48th of the total shares underlying the RSU Award vesting on May 18, 2022 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares subject to the RSU Award shall vest quarterly over four years, with 4/48th of the total shares underlying the RSU Award vesting on May 18, 2022 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18."}],"balance_after":13442,"derivative":{"underlying":"Common Stock","underlying_shares":1752},"source":{"system":"sec-edgar","filing":"0001415889-24-004886","document":"form4-02222024_100242.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000141588924004886/form4-02222024_100242.xml","form_type":"4"}},{"id":1624467,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-02-22T22:34:52.000Z","date":"2024-02-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":683,"price":8.38,"value":5723.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by and surrendered to the Issuer on February 20, 2024, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award."}],"balance_after":94469,"source":{"system":"sec-edgar","filing":"0001415889-24-004886","document":"form4-02222024_100242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000141588924004886/form4-02222024_100242.xml","form_type":"4"}},{"id":1624466,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-02-22T22:34:52.000Z","date":"2024-02-20","kind":"exercise","planned":false,"acquired":true,"shares":1752,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":95152,"source":{"system":"sec-edgar","filing":"0001415889-24-004886","document":"form4-02222024_100242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000141588924004886/form4-02222024_100242.xml","form_type":"4"}},{"id":1699222,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-27T22:36:45.000Z","date":"2023-12-26","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":9.5,"value":28500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.48 to $9.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":93400,"source":{"system":"sec-edgar","filing":"0001209191-23-059819","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123059819/doc4.xml","form_type":"4"}},{"id":1729305,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-28T01:53:53.000Z","date":"2023-11-24","kind":"sale","planned":false,"acquired":false,"shares":3000,"price":6.94,"value":20820.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.67 to $7.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":96400,"source":{"system":"sec-edgar","filing":"0001209191-23-056733","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123056733/doc4.xml","form_type":"4"}},{"id":1732128,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-11-21T22:52:24.000Z","date":"2023-11-18","kind":"exercise","planned":false,"acquired":false,"shares":3681,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the RSU Award shall vest over four years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2024 and each March 10 thereafter, until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares subject to the RSU Award shall vest over four years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2024 and each March 10 thereafter, until fully vested."}],"balance_after":49090,"derivative":{"underlying":"Common Stock","underlying_shares":3681},"source":{"system":"sec-edgar","filing":"0001209191-23-056349","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123056349/doc4.xml","form_type":"4"}},{"id":1732127,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-11-21T22:52:24.000Z","date":"2023-11-18","kind":"exercise","planned":false,"acquired":false,"shares":1752,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the RSU Award shall vest quarterly over four years, with 4/48th of the total shares underlying the RSU Award vesting on May 18, 2022 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares subject to the RSU Award shall vest quarterly over four years, with 4/48th of the total shares underlying the RSU Award vesting on May 18, 2022 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18."}],"balance_after":15194,"derivative":{"underlying":"Common Stock","underlying_shares":1752},"source":{"system":"sec-edgar","filing":"0001209191-23-056349","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123056349/doc4.xml","form_type":"4"}},{"id":1732126,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-21T22:52:24.000Z","date":"2023-11-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":1434,"price":5.98,"value":8575.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by and surrendered to the Issuer on November 18, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award."}],"balance_after":99400,"source":{"system":"sec-edgar","filing":"0001209191-23-056349","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123056349/doc4.xml","form_type":"4"}},{"id":1732125,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-21T22:52:24.000Z","date":"2023-11-18","kind":"exercise","planned":false,"acquired":true,"shares":3681,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":100834,"source":{"system":"sec-edgar","filing":"0001209191-23-056349","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123056349/doc4.xml","form_type":"4"}},{"id":1732124,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-21T22:52:24.000Z","date":"2023-11-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":683,"price":5.98,"value":4084.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by and surrendered to the Issuer on November 18, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award."}],"balance_after":97153,"source":{"system":"sec-edgar","filing":"0001209191-23-056349","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123056349/doc4.xml","form_type":"4"}},{"id":1732123,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-21T22:52:24.000Z","date":"2023-11-18","kind":"exercise","planned":false,"acquired":true,"shares":1752,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":97836,"source":{"system":"sec-edgar","filing":"0001209191-23-056349","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123056349/doc4.xml","form_type":"4"}},{"id":1755104,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-10-25T22:29:59.000Z","date":"2023-10-24","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":4.68,"value":14040.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.48 to $4.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":96084,"source":{"system":"sec-edgar","filing":"0001209191-23-053595","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123053595/doc4.xml","form_type":"4"}},{"id":1773016,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-26T22:42:43.000Z","date":"2023-09-25","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":6.38,"value":19140.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.25 to $6.42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":99084,"source":{"system":"sec-edgar","filing":"0001209191-23-050611","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123050611/doc4.xml","form_type":"4"}},{"id":1794983,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-28T21:37:55.000Z","date":"2023-08-24","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":7.69,"value":23070.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.58 to $7.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":102084,"source":{"system":"sec-edgar","filing":"0001209191-23-047533","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123047533/doc4.xml","form_type":"4"}},{"id":1800397,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-08-22T00:21:54.000Z","date":"2023-08-18","kind":"exercise","planned":false,"acquired":false,"shares":3681,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the RSU Award shall vest over four years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2024 and each March 10 thereafter, until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares subject to the RSU Award shall vest over four years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2024 and each March 10 thereafter, until fully vested."}],"balance_after":52771,"derivative":{"underlying":"Common Stock","underlying_shares":3681},"source":{"system":"sec-edgar","filing":"0001209191-23-046833","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123046833/doc4.xml","form_type":"4"}},{"id":1800396,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-08-22T00:21:54.000Z","date":"2023-08-18","kind":"exercise","planned":false,"acquired":false,"shares":1752,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the RSU Award shall vest quarterly over four years, with 4/48th of the total shares underlying the RSU Award vesting on May 18, 2022 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares subject to the RSU Award shall vest quarterly over four years, with 4/48th of the total shares underlying the RSU Award vesting on May 18, 2022 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18."}],"balance_after":16946,"derivative":{"underlying":"Common Stock","underlying_shares":1752},"source":{"system":"sec-edgar","filing":"0001209191-23-046833","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123046833/doc4.xml","form_type":"4"}},{"id":1800395,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-22T00:21:54.000Z","date":"2023-08-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":1434,"price":8.46,"value":12131.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by and surrendered to the Issuer on August 18, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award."}],"balance_after":105084,"source":{"system":"sec-edgar","filing":"0001209191-23-046833","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123046833/doc4.xml","form_type":"4"}},{"id":1800394,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-22T00:21:54.000Z","date":"2023-08-18","kind":"exercise","planned":false,"acquired":true,"shares":3681,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":106518,"source":{"system":"sec-edgar","filing":"0001209191-23-046833","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123046833/doc4.xml","form_type":"4"}},{"id":1800393,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-22T00:21:54.000Z","date":"2023-08-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":683,"price":8.46,"value":5778.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by and surrendered to the Issuer on August 18, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award."}],"balance_after":102837,"source":{"system":"sec-edgar","filing":"0001209191-23-046833","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123046833/doc4.xml","form_type":"4"}},{"id":1800392,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-22T00:21:54.000Z","date":"2023-08-18","kind":"exercise","planned":false,"acquired":true,"shares":1752,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":103520,"source":{"system":"sec-edgar","filing":"0001209191-23-046833","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123046833/doc4.xml","form_type":"4"}},{"id":1823364,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-07-25T22:22:45.000Z","date":"2023-07-24","kind":"sale","planned":true,"acquired":true,"shares":3000,"price":9.17,"value":27510.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.95 to $9.27, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":101768,"source":{"system":"sec-edgar","filing":"0001209191-23-043340","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123043340/doc4.xml","form_type":"4"}},{"id":1843208,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-27T23:06:03.000Z","date":"2023-06-26","kind":"sale","planned":false,"acquired":false,"shares":3000,"price":7.96,"value":23880.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2022, as last modified on September 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.90 to $8.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":104768,"source":{"system":"sec-edgar","filing":"0001209191-23-039967","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123039967/doc4.xml","form_type":"4"}},{"id":1877589,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-25T21:42:03.000Z","date":"2023-05-24","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":7.76,"value":23280.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2022, as last modified on September 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.49 to $7.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":107768,"source":{"system":"sec-edgar","filing":"0001209191-23-032259","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123032259/doc4.xml","form_type":"4"}},{"id":1883920,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-05-19T23:11:53.000Z","date":"2023-05-18","kind":"exercise","planned":false,"acquired":false,"shares":2454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2024 and each March 10 thereafter, until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2024 and each March 10 thereafter, until fully vested."}],"balance_after":56452,"derivative":{"underlying":"Common Stock","underlying_shares":2454},"source":{"system":"sec-edgar","filing":"0001209191-23-031264","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123031264/doc4.xml","form_type":"4"}},{"id":1883919,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-05-19T23:11:53.000Z","date":"2023-05-18","kind":"exercise","planned":false,"acquired":false,"shares":1752,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the RSU Award shall vest quarterly over four years, with 4/48th of the total shares underlying the RSU Award vesting on May 18, 2022 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares subject to the RSU Award shall vest quarterly over four years, with 4/48th of the total shares underlying the RSU Award vesting on May 18, 2022 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18."}],"balance_after":18698,"derivative":{"underlying":"Common Stock","underlying_shares":1752},"source":{"system":"sec-edgar","filing":"0001209191-23-031264","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123031264/doc4.xml","form_type":"4"}},{"id":1883918,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-19T23:11:53.000Z","date":"2023-05-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":956,"price":6.69,"value":6395.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by and surrendered to the Issuer on May 18, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award."}],"balance_after":110768,"source":{"system":"sec-edgar","filing":"0001209191-23-031264","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123031264/doc4.xml","form_type":"4"}},{"id":1883917,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-19T23:11:53.000Z","date":"2023-05-18","kind":"exercise","planned":false,"acquired":true,"shares":2454,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":111724,"source":{"system":"sec-edgar","filing":"0001209191-23-031264","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123031264/doc4.xml","form_type":"4"}},{"id":1883916,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-19T23:11:53.000Z","date":"2023-05-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":683,"price":6.69,"value":4569.27,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by and surrendered to the Issuer on May 18, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award."}],"balance_after":109270,"source":{"system":"sec-edgar","filing":"0001209191-23-031264","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123031264/doc4.xml","form_type":"4"}},{"id":1883915,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-19T23:11:53.000Z","date":"2023-05-18","kind":"exercise","planned":false,"acquired":true,"shares":1752,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":109953,"source":{"system":"sec-edgar","filing":"0001209191-23-031264","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123031264/doc4.xml","form_type":"4"}},{"id":1913922,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-04-25T22:43:59.000Z","date":"2023-04-24","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":10.24,"value":30720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2022, as last modified on September 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.12 to $10.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":108201,"source":{"system":"sec-edgar","filing":"0001209191-23-025617","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123025617/doc4.xml","form_type":"4"}},{"id":1938868,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-25T01:21:22.000Z","date":"2023-03-24","kind":"sale","planned":false,"acquired":false,"shares":3000,"price":8.33,"value":24990.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2022, as last modified on September 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.19 to $8.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":111201,"source":{"system":"sec-edgar","filing":"0001209191-23-021140","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123021140/doc4.xml","form_type":"4"}},{"id":1964771,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-03-08T00:47:19.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":58906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2024 and each March 10 thereafter, until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2024 and each March 10 thereafter, until fully vested."}],"balance_after":58906,"derivative":{"underlying":"Common Stock","underlying_shares":58906},"source":{"system":"sec-edgar","filing":"0001209191-23-016978","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123016978/doc4.xml","form_type":"4"}},{"id":1964770,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-03-08T00:47:19.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":89031,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option shall vest monthly over four years from the vesting commencement date of March 3, 2023. The option becomes fully vested on March 3, 2027."}],"balance_after":89031,"derivative":{"exercise_price":10.61,"expiration_date":"2033-03-03","underlying":"Common Stock","underlying_shares":89031},"source":{"system":"sec-edgar","filing":"0001209191-23-016978","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123016978/doc4.xml","form_type":"4"}},{"id":1985847,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-28T23:48:41.000Z","date":"2023-02-24","kind":"sale","acquired":false,"shares":3000,"price":11.05,"value":33150.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2022, as last modified on September 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.80 to $11.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":114201,"source":{"system":"sec-edgar","filing":"0001209191-23-013889","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123013889/doc4.xml","form_type":"4"}},{"id":1995128,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-02-23T23:37:18.000Z","date":"2023-02-21","kind":"exercise","acquired":false,"shares":1752,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the RSU Award shall vest quarterly over four years, with 4/48th of the total shares underlying the RSU Award vesting on May 18, 2022 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares subject to the RSU Award shall vest quarterly over four years, with 4/48th of the total shares underlying the RSU Award vesting on May 18, 2022 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18."}],"balance_after":20450,"derivative":{"underlying":"Common Stock","underlying_shares":1752},"source":{"system":"sec-edgar","filing":"0001209191-23-012352","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123012352/doc4.xml","form_type":"4"}},{"id":1995127,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-23T23:37:18.000Z","date":"2023-02-21","kind":"tax_withholding","acquired":false,"shares":683,"price":10.97,"value":7492.51,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by and surrendered to the Issuer on February 21, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award."}],"balance_after":117201,"source":{"system":"sec-edgar","filing":"0001209191-23-012352","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123012352/doc4.xml","form_type":"4"}},{"id":1995126,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-23T23:37:18.000Z","date":"2023-02-21","kind":"exercise","acquired":true,"shares":1752,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":117884,"source":{"system":"sec-edgar","filing":"0001209191-23-012352","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123012352/doc4.xml","form_type":"4"}},{"id":1995125,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-02-23T23:34:53.000Z","date":"2022-09-08","kind":"exercise","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest as follows: 25% of the shares subject to the option vests on October 15, 2019; and 1/48th of the shares subject to the option vest monthly thereafter over the following three years."}],"balance_after":202661,"derivative":{"exercise_price":0.4,"expiration_date":"2029-01-11","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-23-012351","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123012351/doc4.xml","form_type":"4"}},{"id":1995124,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-23T23:34:53.000Z","date":"2022-09-08","kind":"exercise","acquired":true,"shares":40000,"price":0.4,"value":16000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Forms 4 filed after the date of the option exercise reported in this Form 4 incorrectly underreported total ownership by 40,000 shares.  The number of securities beneficially owned following this option exercise is reflected as of February 17, 2022."}],"balance_after":116132,"source":{"system":"sec-edgar","filing":"0001209191-23-012351","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123012351/doc4.xml","form_type":"4"}},{"id":2046130,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-26T00:20:03.000Z","date":"2023-01-24","kind":"sale","acquired":false,"shares":3500,"price":11.05,"value":38675.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2022, as last modified on September 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.80 to $11.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":76132,"source":{"system":"sec-edgar","filing":"0001209191-23-004922","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919123004922/doc4.xml","form_type":"4"}},{"id":2074751,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-29T18:03:38.000Z","date":"2022-12-27","kind":"sale","acquired":false,"shares":3500,"price":9.77,"value":34195.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.65 to $9.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":79632,"source":{"system":"sec-edgar","filing":"0001209191-22-062882","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919122062882/doc4.xml","form_type":"4"}},{"id":2103117,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-11-28T23:55:56.000Z","date":"2022-11-25","kind":"sale","acquired":false,"shares":3500,"price":14.3,"value":50050.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.18 to $14.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":83132,"source":{"system":"sec-edgar","filing":"0001209191-22-058890","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919122058890/doc4.xml","form_type":"4"}},{"id":2106180,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-11-22T23:04:00.000Z","date":"2022-11-18","kind":"exercise","acquired":false,"shares":1752,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the RSU Award shall vest quarterly over four years, with 4/48th of the total shares underlying the RSU Award vesting on May 18, 2022 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares subject to the RSU Award shall vest quarterly over four years, with 4/48th of the total shares underlying the RSU Award vesting on May 18, 2022 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18."}],"balance_after":22202,"derivative":{"underlying":"Common Stock","underlying_shares":1752},"source":{"system":"sec-edgar","filing":"0001209191-22-058467","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919122058467/doc4.xml","form_type":"4"}},{"id":2106179,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-11-22T23:04:00.000Z","date":"2022-11-18","kind":"tax_withholding","acquired":false,"shares":683,"price":14.75,"value":10074.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by and surrendered to the Issuer on November 18, 2022, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award."}],"balance_after":86632,"source":{"system":"sec-edgar","filing":"0001209191-22-058467","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919122058467/doc4.xml","form_type":"4"}},{"id":2106178,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-11-22T23:04:00.000Z","date":"2022-11-18","kind":"exercise","acquired":true,"shares":1752,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":87315,"source":{"system":"sec-edgar","filing":"0001209191-22-058467","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919122058467/doc4.xml","form_type":"4"}},{"id":2132139,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-10-25T21:38:02.000Z","date":"2022-10-24","kind":"sale","acquired":false,"shares":3500,"price":15.16,"value":53060.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.82 to $15.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":85563,"source":{"system":"sec-edgar","filing":"0001209191-22-054563","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919122054563/doc4.xml","form_type":"4"}},{"id":2149744,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-09-28T21:38:18.000Z","date":"2022-09-26","kind":"sale","acquired":false,"shares":3500,"price":12.63,"value":44205.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.44 to $12.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":89063,"source":{"system":"sec-edgar","filing":"0001209191-22-051488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919122051488/doc4.xml","form_type":"4"}},{"id":2173618,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-25T22:14:04.000Z","date":"2022-08-24","kind":"sale","acquired":false,"shares":3500,"price":13.45,"value":47075.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2022."}],"balance_after":92563,"source":{"system":"sec-edgar","filing":"0001209191-22-047576","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919122047576/doc4.xml","form_type":"4"}},{"id":2177810,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-08-19T23:33:13.000Z","date":"2022-08-18","kind":"exercise","acquired":false,"shares":1752,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the RSU Award shall vest quarterly over four years, with 4/48th of the total shares underlying the RSU Award vesting on May 18, 2022 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares subject to the RSU Award shall vest quarterly over four years, with 4/48th of the total shares underlying the RSU Award vesting on May 18, 2022 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18."}],"balance_after":23954,"derivative":{"underlying":"Common Stock","underlying_shares":1752},"source":{"system":"sec-edgar","filing":"0001209191-22-046946","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919122046946/doc4.xml","form_type":"4"}},{"id":2177809,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-19T23:33:13.000Z","date":"2022-08-18","kind":"tax_withholding","acquired":false,"shares":683,"price":14.06,"value":9602.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by and surrendered to the Issuer on August 18, 2022, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award."}],"balance_after":96063,"source":{"system":"sec-edgar","filing":"0001209191-22-046946","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919122046946/doc4.xml","form_type":"4"}},{"id":2177808,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-19T23:33:13.000Z","date":"2022-08-18","kind":"exercise","acquired":true,"shares":1752,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":96746,"source":{"system":"sec-edgar","filing":"0001209191-22-046946","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919122046946/doc4.xml","form_type":"4"}},{"id":2195096,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-03T21:49:04.000Z","date":"2022-08-01","kind":"sale","acquired":false,"shares":3500,"price":12.8,"value":44800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.62 to $12.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,071 shares acquired by the Reporting Person under the Issuer's 2021 Employee Stock Purchase Plan on May 31, 2022."}],"balance_after":94994,"source":{"system":"sec-edgar","filing":"0001209191-22-044309","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919122044309/doc4.xml","form_type":"4"}},{"id":2261224,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-05-20T23:12:47.000Z","date":"2022-05-18","kind":"exercise","acquired":false,"shares":2336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the RSU Award shall vest quarterly over four years, with 4/48th of the total shares underlying the RSU Award vesting on May 18, 2022 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares subject to the RSU Award shall vest quarterly over four years, with 4/48th of the total shares underlying the RSU Award vesting on May 18, 2022 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18."}],"balance_after":25706,"derivative":{"underlying":"Common Stock","underlying_shares":2336},"source":{"system":"sec-edgar","filing":"0001209191-22-031164","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919122031164/doc4.xml","form_type":"4"}},{"id":2261223,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-20T23:12:47.000Z","date":"2022-05-18","kind":"tax_withholding","acquired":false,"shares":910,"price":9.65,"value":8781.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by and surrendered to the Issuer on May 18, 2022, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award."}],"balance_after":97423,"source":{"system":"sec-edgar","filing":"0001209191-22-031164","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919122031164/doc4.xml","form_type":"4"}},{"id":2261222,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-20T23:12:47.000Z","date":"2022-05-18","kind":"exercise","acquired":true,"shares":2336,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":98333,"source":{"system":"sec-edgar","filing":"0001209191-22-031164","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919122031164/doc4.xml","form_type":"4"}},{"id":2359150,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-03-02T22:54:05.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":28042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the RSU Award shall vest quarterly over four years, with 4/48th of the total shares underlying the RSU Award vesting on May 18, 2022 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares subject to the RSU Award shall vest quarterly over four years, with 4/48th of the total shares underlying the RSU Award vesting on May 18, 2022 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18."}],"balance_after":28042,"derivative":{"underlying":"Common Stock","underlying_shares":28042},"source":{"system":"sec-edgar","filing":"0001209191-22-014992","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919122014992/doc4.xml","form_type":"4"}},{"id":2359149,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-02T22:54:05.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":42310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest monthly over four years from the vesting commencement date of January 1, 2022.  The option becomes fully vested on January 1, 2026."}],"balance_after":42310,"derivative":{"exercise_price":13.64,"expiration_date":"2032-02-28","underlying":"Common Stock","underlying_shares":42310},"source":{"system":"sec-edgar","filing":"0001209191-22-014992","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919122014992/doc4.xml","form_type":"4"}},{"id":2624614,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":93080,"kind":"person","name":"Jeanmonod Patrik","position":1,"cik":"0001873085","reported_name":"Jeanmonod Patrik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-27T01:49:47.000Z","date":"2021-07-22","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest as follows: 25% of the shares subject to the option vests on July 22, 2022; and 1/48th of the shares subject to the option vest monthly thereafter over the following three years."}],"balance_after":125000,"derivative":{"exercise_price":17,"expiration_date":"2031-07-22","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-21-048268","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831915/000120919121048268/doc4.xml","form_type":"4"}}]}